Does the 'Oxygen cost diagram' reflect changes in six minute walking distance in follow up studies?

Respiratory Medicine

Volumn 93, Issue 11, 1999, Pages 810-815

  Janssens, J P ^a,c   Breitenstein, E ^b   Rochat, T ^a   Fitting, J W ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c Hopital de Rolle   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AGED; ANXIETY; ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DYSPNEA; EXERCISE TOLERANCE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MALE; MOBILIZATION; PRIORITY JOURNAL; QUALITY OF LIFE; REGRESSION ANALYSIS; VITAL CAPACITY; WALKING;

EID: 0032721937     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(99)90266-4     Document Type: Article

References (32)

1. McGavin CR, Artvinli M, Naoe H, McHardy GJR. Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease. Br Med J 1978; 2: 241-243.
2. Curtis JR, Deyo RA, Hudson LD. Health-related quality of life among patients with COPD. Thorax 1994; 49: 162-170.
3. Mahler D. The role of theophylline in the treatment of dyspnoea in COPD. Chest 1992; 1: 2S-6S.
4. Eaton M, MacDonald F, Church T, Niewoehner D. Effects of theophylline on breathlessness and exercise tolerance in patients with chronic airflow obstruction. Chest 1982; 82: 538-542.
5. Morrison J, Jones P, Muers M. Assessing physiological benefit from domiciliary nebulized bronchodilators in severe airflow limitation. Eur Respir J 1992; 5: 424-429.
6. Dullinger D, Kronenberg R, Niewoehner D. Efficacy of inhaled metaproterenol and orally-administered theophylline in patients with chronic airflow obstruction. Chest 1986; 89: 171-173.
7. Guyatt G, Townsend M, Keller J, Singer J, Nograd S. Measuring functional status in chronic lung disease: conclusions from a randomized control trial. Respir Med 1991; 85 (Suppl.B): 17-21.
8. Bergmann K. Controlled clinical comparative evaluation of fluticasone powder inhalation versus flunisoloide dose aerosol in patients with mild to moderate asthma. Pneumologie 1997; 51: 27-32.
9. Hall T, Kasik J, Bedell G, Schaiff R. The efficacy of inhaled beclomethasone in chronic obstructive airway disease. Pharmacotherapy 1989; 9: 232-239.
10. Woodcock A, Gross E, Geddes D. Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers. Br Med J 1981; 283: 343-346.
11. Jenkinson C, Jenkinson D, Shepperd S, Layte R, Petersen S. Evaluation of treatment for congestive heart failure in patients aged 60 years and older using generic measures of health status (SF-36 and COOP charts). Age Ageing 1997; 26: 7-13.
12. Janssens JP, Rochat T, Frey JG, Dousse N, Pichard C, Tschopp JM. Health-related quality of life in patients under long term oxygen therapy: a home-based descriptive study. Respir Med 1997; 91: 592-602.
13. Janssens JP, Penalosa B, Degive C, Rabeus M, Rochat T. Quality of life of patients under home mechanical ventilation for restrictive lung diseases: a comparative evaluation with COPD patients. Monaldi Arch Chest Dis 1996; 51: 178-184.
14. Johnson M, Woodcock A, Rehahn M, Geddes D. Are "pink puffers" more breathless than "blue bloaters"? Br Med J 1983; 286: 179-182.
15. Read C, Clauw D, Weir C, Taveira Da Silva A, Katz P. Dyspnoea and pulmonary function in the L-tryptophan-associated eosinophilia myalgia syndrome. Chest 1992; 101: 1282-1286.
16. Wegner RE, Jörres RA, Kirsten DK, Magnussen H. Factor analysis of exercice capacity, dyspnoea ratings and lung function in patients with severe COPD. Eur Respir J 1994; 7: 725-729.
17. Mahler D, Harver A. A factor analysis of dyspnoea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 145: 467-470.
18. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Analysis of clinical methods used to evaluate dyspnoea in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1185-1189.
19. Guyatt GH, Berman LB, Townsend M, Pugsley SP, Chambers LW. A measure of quality of life for clincal trials in chronic lung disease. Thorax 1987; 42: 773-778.
20. Donner CF, Howard P, Robert D. Patient selection and techniques for home mechanical ventilation. Monaldi Arch Chest Dis 1993; 48: 40-47.
21. American Thoracic Society. Standardization of spirometry: 1994 Update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
22. Quanjer P, Tammeling G, Cotes J, Pederson O, Peslin R, Yernault J. Lung volumes and forced expiratory flows. Eur Respir J Suppl 1993; 16: 5-40.
23. McGavin CR, Gupta SP, McHardy GJR. Twelve-minute walking test for assessing disability in chronic bronchitis. Br Med J 1976; 1: 822-823.
24. Borg GAV. Psychophysical bases of perceived exertion. Med Sci Sports Exercise 1982; 14: 377-381.
25. Wilson R, Jones P. A comparison of the visual analogue scale and modified Borg scale for the measurement of dyspnoea during exercise. Clinical Science 1989; 76: 277-282.
26. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta psychiatr scand 1983; 67: 361-370.
27. Lepine JP, Godchau M, Brun P, Lempérière T. Evaluation de l'anxiété et de la dépression chez des patients hospitalisés dans un service de médecine interne (Evaluation of anxiety and depression in patients hospitalized in an internal medecine ward). Ann Med Psychol 1985; 143: 175-189.
28. Janssens JP, Cicotti E, Fitting J, Rochat T. Non-invasive home ventilation in patients over 75 years of age: tolerance, compliance, and impact on quality of life. Respir Med 1998; 92: 1311-1320.
29. Mahler DA. Dyspnoea: Diagnosis and Management. Clin Chest Med 1987; 8: 215-230.
30. Farncombe M. Dyspnoea: assessment and treatment. Support Care Cancer 1997; 5: 94-99.
31. Viramontes J, O'Brien B. Relationship between symptoms and health-related quality of life in chronic lung disease. J Gen Intern Med 1994; 9: 46.
32. Noseda A, Yernault J. Quantifying dyspnea. Presse Med 1994; 23: 1527-1532.